Updated Jul 16, 2026
Gault Cheryl has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.10M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale | 1.0K | $43.15 | $43K |
| 2026-07-01 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale | 3.3K | $42.17 | $140K |
| 2026-07-01 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale | 3.8K | $41.39 | $157K |
| 2026-07-01 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale | 1.9K | $40.09 | $76K |
| 2026-03-31 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale [10b5-1] | 2.8K | $28.55 | $81K |
| 2026-03-31 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale [10b5-1] | 7.2K | $28.04 | $201K |
| 2026-03-09 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale | 2.0K | $28.93 | $58K |
| 2025-12-01 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale [10b5-1] | 5.0K | $30.10 | $150K |
| 2025-12-01 | RAPP | Rapport Therapeutics, Inc. | M — Option exercise [10b5-1] | 5.0K | $1.80 | $9K |
| 2025-09-08 | RAPP | Rapport Therapeutics, Inc. | S — Open-market sale | 5.0K | $38.33 | $192K |
| 2025-09-08 | RAPP | Rapport Therapeutics, Inc. | M — Option exercise | 5.0K | $1.80 | $9K |
Gault Cheryl is a corporate insider — currently tracked as Insider of Rapport Therapeutics, Inc. (RAPP). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 9 open-market sales ($1.10M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Gault Cheryl profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.